Literature DB >> 10080828

Conditioned immune response to interferon-gamma in humans.

D L Longo1, P L Duffey, W C Kopp, M P Heyes, W G Alvord, W H Sharfman, P J Schmidt, D R Rubinow, D L Rosenstein.   

Abstract

We determined whether a classical conditioning paradigm may be used to condition immunologic responses in normal human subjects receiving an optimal immunostimulating dose of recombinant human interferon-gamma (rhIFN-gamma). We conducted a placebo-controlled, double-blind study of 31 normal volunteers in order to determine whether an initially immune-neutral stimulus, oral propylene glycol (PG), could eventually elicit an immune response as a consequence of its being paired with a known immunostimulatory dose and schedule of rhIFN-gamma. Subjects were randomly assigned to one of three groups: (A) rhIFN-gamma injections paired with PG; (B) normal saline injections paired with PG; (C) rhIFN-gamma injections alone. During the 4-week study, subjects received progressively fewer injections so that, by the final week of the study, no injections were given and groups A and B received only PG. The principal outcome measures were serum concentrations of quinolinic acid (QUIN) and neopterin, two nonspecific but sensitive markers of immune activation, and expression of Fc receptors (CD64) on peripheral blood mononuclear cells. RhIFN-gamma injections produced significant and predictable alterations in each of the measured immune parameters. No group B subject made an immune response. Mean serum QUIN levels were significantly higher at the end of week three for subjects in the experimental condition (group A) than for subjects receiving rhIFN-gamma alone (group C) despite receiving identical doses of rhIFN-gamma. Similarly, the predicted decay in mean serum neopterin levels from the end of week 1 to the end of week 2 was seen in group C but not in group A. The exposure of group A to PG blunted the decline of CD64 expression in week four. The data suggest that the pairing of an unconditioned stimulus (rhIFN-gamma) and a conditioned stimulus (PG) permits the conditioned stimulus alone to prolong a cytokine-induced response in normal humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10080828     DOI: 10.1006/clim.1998.4637

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  10 in total

Review 1.  Brain-immune interactions and the neural basis of disease-avoidant ingestive behaviour.

Authors:  Gustavo Pacheco-López; Federico Bermúdez-Rattoni
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-12-12       Impact factor: 6.237

Review 2.  Behavioural conditioning as the mediator of placebo responses in the immune system.

Authors:  Sabine Vits; Elvir Cesko; Paul Enck; Uwe Hillen; Dirk Schadendorf; Manfred Schedlowski
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

Review 3.  Neural regulation of immunity: molecular mechanisms and clinical translation.

Authors:  Valentin A Pavlov; Kevin J Tracey
Journal:  Nat Neurosci       Date:  2017-01-16       Impact factor: 24.884

4.  Impairments in Peripheral Blood T Effector and T Regulatory Lymphocytes in Bipolar Disorder Are Associated with Staging of Illness and Anti-cytomegalovirus IgG Levels.

Authors:  Michael Maes; Joao Victor Nani; Cristiano Noto; Lucas Rizzo; Mirian A F Hayashi; Elisa Brietzke
Journal:  Mol Neurobiol       Date:  2020-09-11       Impact factor: 5.590

Review 5.  Placebo and the new physiology of the doctor-patient relationship.

Authors:  Fabrizio Benedetti
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

Review 6.  Neurobiological mechanisms of placebo responses.

Authors:  Jon-Kar Zubieta; Christian S Stohler
Journal:  Ann N Y Acad Sci       Date:  2009-03       Impact factor: 5.691

Review 7.  Learned immunosuppression: extinction, renewal, and the challenge of reconsolidation.

Authors:  Martin Hadamitzky; Harald Engler; Manfred Schedlowski
Journal:  J Neuroimmune Pharmacol       Date:  2012-07-13       Impact factor: 4.147

8.  Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial.

Authors:  Nicholas I Paton; Ruth L Goodall; David T Dunn; Samuel Franzen; Yolanda Collaco-Moraes; Brian G Gazzard; Ian G Williams; Martin J Fisher; Alan Winston; Julie Fox; Chloe Orkin; Elbushra A Herieka; Jonathan G Ainsworth; Frank A Post; Mark Wansbrough-Jones; Peter Kelleher
Journal:  JAMA       Date:  2012-07-25       Impact factor: 56.272

Review 9.  Neuronal regulation of immunity: why, how and where?

Authors:  Maya Schiller; Tamar L Ben-Shaanan; Asya Rolls
Journal:  Nat Rev Immunol       Date:  2020-08-18       Impact factor: 53.106

10.  Placebo effects on the immune response in humans: the role of learning and expectation.

Authors:  Antje Albring; Laura Wendt; Sven Benson; Oliver Witzke; Andreas Kribben; Harald Engler; Manfred Schedlowski
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.